Home \ Expert Opinion \ Rehabilitation after a stroke

Rehabilitation after a stroke

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
Rehabilitation methods after stroke
02:55
Basic principles of rehabilitation after stroke
06:40
The role of the attending physician in the rehabilitation of a patient with a stroke
08:50
The role of the therapist in the rehabilitation of patients after stroke
10:23
The main syndromes of patients after stroke
15:00
Screening scales to assess the condition of patients
16:48
Medication rehabilitation and the choice of drugs
18:20
Restoration of neuroplasticity
22:00
The evidence base of Mexidol® after a stroke
25:10
Stroke and rehabilitation prevention: opportunities and tasks

Ostroumova Olga Dmitrievna - MD, professor, head. Department of Therapy and Polymorbid Pathology. Academician M.S. VLUSSi FSBEI DPO RMANPO of the Ministry of Health of Russia

Kovalchuk Vitaly Vladimirovich -MD, professor, chairman of the Society of Rehabilitologists of St. Petersburg, head. department of neurological rehabilitation of St. Petersburg GBUZ "City Hospital No. 38 named after N.A. Semashko "

Announcement:

It was previously believed that rehabilitation after a stroke should be delayed for several days or weeks in order not to harm the patient. But recent studies have shown that rehabilitation must begin from the first hours in order to avoid severe complications, such as non -class syndrome, muscle spasticism, pain syndromes, psychoemotional and cognitive disorders. Rehabilitation is based on two principles - a multidisciplinary approach to the consequences of a stroke and timely medical support in order to form adequate intersneal ties - one of the main criteria of neuroplasticity.

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

00:00
Rehabilitation methods after stroke
02:55
Basic principles of rehabilitation after stroke
06:40
The role of the attending physician in the rehabilitation of a patient with a stroke
08:50
The role of the therapist in the rehabilitation of patients after stroke
10:23
The main syndromes of patients after stroke
15:00
Screening scales to assess the condition of patients
16:48
Medication rehabilitation and the choice of drugs
18:20
Restoration of neuroplasticity
22:00
The evidence base of Mexidol® after a stroke
25:10
Stroke and rehabilitation prevention: opportunities and tasks

Block of articles on this topic

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in acute and early restorations. Periods

Authors:
L.V. Stakhovskaya ¹ , N.A. Shamalov ¹ , DR Khasanova ² , E.V. Melnikova ³ , A.S. Agafin ⁴ , K.V. Golikov ⁵ , E.I. Bogdanov ⁶ , A.A. Yakupova ⁶ , L.V. Roshkovskaya ⁷ , L.V. Lukin ⁸ , T.M. Lokstanova ⁹ , I.E. Patrunenova ¹⁰ , L.A. Shchepankevich ¹ ¹

¹ Research Institute of Cerebrovascular Pathology and Stroke of the Federal State Budgetary Institution “Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
² GAUZ "Interregional Clinical and Diagnostic Center", Kazan, Russia;
³ St. Petersburg GBUZ "City Hospital No. 26", St. Petersburg, Russia;
⁴ St. Petersburg GBUZ "City Hospital No. 40 of the Resort Administrative District", St. Petersburg, Russia;
⁵ St. Petersburg GBUZ "City multidisciplinary hospital No. 2", St. Petersburg, Russia;
⁶ FSBEI in Kazan State Medical University of the Ministry of Health of Russia, Kazan, Russia;
⁷ St. Petersburg GBUZ "Nikolaev Hospital", St. Petersburg, Russia;
⁸ GBUZ "Vsevolozhsk Clinical Interdistrict Hospital", Leningrad Region, Russia;
⁹ Mubz "City Clinical Hospital No. 1 named after N.I. Pirogov ", Samara, Russia;
¹⁰ GBUZ "Samara Regional Clinical Hospital named after V.D. Seredavina ”, Samara, Russia;
¹¹ FGBNU "Scientific Institute of Experimental and Clinical Medicine", Novosibirsk, Russia.

The effect of therapy with the drug Mexol on the regression of neurological deficiency and a functional outcome in patients with ischemic stroke: a systematic review and meta analysis

Authors:
I.A. Voznyuk ^1.2 , S.V. Kolomensev ^2.3 , E.M. Morozova ¹

Features of the treatment and rehabilitation of patients who suffered Covid-19 with ischemic stroke

Authors:
G.S. Rakhimbayeva, Sh.R. Gazieva, M.K. Atyaniyazov, F.Kh. Muratov, D.S. Tolipov, U.D. Shodiev

Tashkent Medical Academy, Tashkent, Republic of Uzbekistan

Review of clinical recommendations for the treatment and prevention of ischemic stroke

Author:
A.I. Fedin, K.R. Badalyan

FSBEI in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The effectiveness of the use of ethylmethylhydroxypyridine of succinate in the restoration treatment of patients who have undergone ischemic stroke

Authors:
M.V. Zhuravlev ^1.2 , A.B. Prokofiev ^1.2 , V.V. Arkhipov ¹ , S.Yu. Serebrova ^1.2 , G.I. Gorodetskaya ^1.2 , O.A. Demidova ¹

¹ FSBI “Scientific Center for Expertise of Medical Application” of the Ministry of Health of Russia, Moscow, Russia;
² FGAOU VO "First Moscow State Medical University named after THEM. Sechenov "Ministry of Health of Russia (Sechenov University), Moscow, Russia

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com